NCT01769560View on ClinicalTrials.gov

MeFirst: A Tailored Intervention to HPV Vaccine Decision Making

NACompletedINTERVENTIONAL
Enrollment

661

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Human Papillomavirus-Related Carcinoma
Interventions
BEHAVIORAL

MeFirst Tailored Intervention

Participants will be lead through MeFirst, an interactive web-based tool that is tailored to their responses during the survey. This tool provides information regarding HPV Vaccination.

Trial Locations (1)

48109

Univeristy of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT01769560 - MeFirst: A Tailored Intervention to HPV Vaccine Decision Making | Biotech Hunter | Biotech Hunter